News

Zibotentan is a novel once daily tablet and works by blocking the endothelin pathway. The Phase III study assessed Zibotentan 10mg added to standard of care treatment in

Bayer claimed that Beyaz is the first OC approved to raise folate levels, in women who choose an OC for birth control, for the purpose of reducing the

According to the CHMP, the benefits from using the drug to treat MS did not justify its risks. Recently, Merck’s MS pill got Austrailian and Russian approval and

In the Phase 1 trial Stedivaze was administered to patients with mild to moderate asthma as a single IV bolus, the same as utilized in the ongoing Phase

NextPharma claims that its Belgian site, Braine-l’Alleud, has extensive know how in aseptic production and packaging including the manufacture of cytotoxic products (lyophilization and solutions) gained over more

Pfizer has initiated the recall as a precautionary step after finding a potential for a leak of the components contained in the wrap, which could cause skin injury

The Committee for Medicinal Products for Human Use (CHMP) recommended approval of Tasigna in the indication based on a pivotal Phase III clinical trial in which Tasigna surpassed

Lexiscan is an A2A adenosine receptor agonist approved for use as a pharmacologic stress agent in radionuclide MPI in patients unable to undergo adequate exercise stress. Lexiscan was

Erin Ascher will be responsible for leading Omnicare’s human resources function, including designing and implementing strategies in the areas of attracting, retaining, developing and rewarding employees. Before joining